Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES
A Global Strategic Business Report

This report analyzes the worldwide markets for Cardiac Rhythm Management (CRM) Devices in Millions of US$ by the following segments: Implantable Cardioverter Defibrillators (ICD), Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) devices.The report provides separate comprehensive analytics for the United States, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 59 companies including many key and niche players worldwide such as Bard Electrophysiology, Biosense Webster, Inc., Boston Scientific Corporation, Biotronik GMBH & Co. KG, Medtronic, Inc., Medtronic CryoCath LP, Vitatron Nederland BV, Philips Healthcare, St. Jude Medical, Inc., and Sorin Group. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-6132  PAGES:    468
PRICE:    $2450  DATE:       July 2009
COMPANIES:  59  MARKET DATA TABLES:   131
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES (Complete Report) Pages : 468   | $2450
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2  
   Data Interpretation & Reporting Level.....I-3
Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Implantable Cardioverter Defibrillators (ICD).....I-3
  
   Pacemaker.....I-4
External Defibrillators.....I-4
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA).....I-4
  
II. EXECUTIVE SUMMARY101$2000
  1. INDUSTRY OVERVIEW.....II-118 $1800  
   A Prelude.....II-1
Market Structure.....II-1
1$300
   Table 1: World Market for Cardiac Rhythm Management Devices (2008 & 2010P): Percentage Market Share Breakdown of Leading Players - Medtronic, St. Jude Medical, Boston Scientific (Guidant), and Others (includes corresponding Graph/Chart).....II-2

Table 2: World Market for High Power CRM Devices (2008 & 2010P): Percentage Market Share Breakdown of Leading Players Medtronic, St. Jude Medical, Boston Scientific (Guidant), and Others (includes corresponding Graph/Chart).....II-2
1$300
   Table 3: World Market for Low Power CRM Devices (2008 & 2010P): Percentage Market Share Breakdown of Leading Players - Medtronic, St. Jude Medical, Boston Scientific (Guidant), and Others (includes corresponding Graph/Chart).....II-3

Table 4: World Market for Implantable Cardioverter Defibrillator (ICD) (2008 & 2010P): Percentage Market Share Breakdown of Leading Players - Medtronic, Boston Scientific (Guidant), St. Jude Medical, and Others (includes corresponding Graph/Chart).....II-3
1$300
   Table 5: World Catheter Ablation Devices Market (2007): Percentage Market Share Breakdown of Leading Players - Johnson & Johnson, St.Jude Medical, Boston Scientific, Bard, Medtronic, CryoCath, and Others (includes corresponding Graph/Chart).....II-4

Table 6: World External Defibrillators Market (2006): Percentage Market Share Breakdown of Leading Players – Medtronic, Philips and Others (includes corresponding Graph/Chart).....II-4

Table 7: World Market for Advanced Cardiac Resynchronization Therapy (CRT) Devices (2005): Percentage Market Share Breakdown of Leading Players – Medtronic, Boston Scientific (Guidant), St. Jude Medical, and Others (includes corresponding Graph/Chart).....II-4
1$300
   Noteworthy Trends & Issues.....II-5
Infamous Product Recalls Throw Growth Off-track.....II-5
Market Shapes Up After the Recall Shock.....II-5
1$100
   Regulatory Riders Knit to Ensure Greater Device Reliability.....II-6
Growing Proportion of Obese Population: A Major Demographic Driver.....II-6
Replacements to Drive the Growth of ICDs .....II-6
Developments in Energy-Based Therapies Augur Well for Cardiac Ablation Treatments
  .....II-6
1$100
   Expanding Applications Lend Traction to Growth.....II-7
Prices of Cardiac Pacemakers Soften.....II-7
1$100
   Heart Patients Using ICD, Enjoy Satisfactory Quality Life.....II-8
Pacemakers Ensure Effective Management of Non-Systolic Heart Failures.....II-8
CRT: An Effective Treatment for Bradycardia, Tachycardia & Fibrillation.....II-8
1$100
   ICDs in Pediatric Care Shows Promise.....II-9
Emerging Therapies for the Treatment of Atrial Fibrillation.....II-9
1$100
   New Generation CRM Devices Feature Superior Benefits.....II-10
MRI-Compatible Pacemakers & ICDs.....II-10
Resistance Against Electronic Interferences.....II-10
1$100
   Confusion Over the Use of CRM Devices Threaten Perceived Effectiveness.....II-111$100
   Breathing Disorders in Patients Implanted with Pacemakers: A Cause for
  Concern.....II-12
Approval of Untested Pacemaker Connectors Raises Eyebrows.....II-12
1$100
   ICD Lead Failure Demands Immediate Attention.....II-13
Pacemaker Hacking Has the Industry Up by Its Ears.....II-13
1$100
   Pacemakers Face Stiff Competition from CRT-D Devices.....II-14
ICDs More Prone to Malfunction than Pacemakers.....II-14
Conclusion.....II-14
1$100
   Technology Innovation: A Futuristic Rumination .....II-15
The Heart to Power CRM Devices: The Future of CRM Therapies.....II-15
Genetic Advances to Yield Replacement for Pacemakers.....II-15
Ablation Technology Undergoing Innovations.....II-15
1$100
   Vein Ablation Catheter Proves Successful in Cases of Paroxysmal Atrial
  Fibrillation.....II-16
Ablation Therapy Useful in Treating Persistent/ Permanent Atrial Fibrillation
  (PPAF).....II-16
Magnetic Navigation: An Innovation in Catheter Ablation.....II-16
1$100
   New Force-Sensing Ablation Catheter Aims to Aid Physician Decision Making.....II-17
Pricing & Reimbursements: Critical Determinants of Growth.....II-17
1$100
   New Guidelines Issued for Safe Management of CRM Devices in the US and
  Europe.....II-18
1$100
  2. REGIONAL MARKET OVERVIEW.....II-1912 $1200  
   2a. THE UNITED STATES.....II-19
A. Market Analysis.....II-19
Outlook.....II-19
Market Overview.....II-19
Demand for Automated External Defibrillators Shoots Up in the US.....II-19
1$100
   Market Share Statistics.....II-20
Table 8: US Market for Implantable Cardioverter Defibrillator (ICD) (2007& 2010): Percentage Breakdown of Player Market Shares - Medtronic, Boston Scientific (Guidant), St Jude Medical, and Others (includes corresponding Graph/Chart).....II-20
1$300
   Table 9: US Market for Core Pacemakers & CRT-P (2007 & 2010): Percentage Breakdown of Player Market Shares - Medtronic, St. Jude, Boston Scientific, and Others (includes corresponding Graph/Chart).....II-21
Cardiovascular Disease Incidence Statistics.....II-21
Table 10: Total Direct Economic Cost of Cardiovascular Diseases (CVDs) in the United States (2009E): Breakdown by Disease Type (In US$ Billion) (includes corresponding Graph/Chart).....II-21
1$300
   Table 11: Total Direct Economic Cost of Cardiovascular Diseases (CVDs) in the United States (2009E): Percentage Breakdown by Type of Expenditure (includes corresponding Graph/Chart).....II-22

Table 12: Prevalence of Cardiovascular Diseases in Adults Over the Age of 20 Years in the United States (2006): Percentage Breakdown by Age and Gender (includes corresponding Graph/Chart).....II-22
1$300
   Table 13: Cardiovascular Diseases in the United States (2006): Percentage Breakdown of Deaths Caused by Cardiovascular Diseases by Type (includes corresponding Graph/Chart).....II-23
B. Market Analytics.....II-23
Table 14: US Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-23
1$300
   Table 15: US Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2005 (includes corresponding Graph/Chart).....II-24

Table 16: US 10-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-24
1$300
   2B. REST OF WORLD.....II-25
A. Market Analysis.....II-25
Outlook.....II-25
Market Share Statistics.....II-25
Table 17: Implantable Cardioverter Defibrillator (ICD) Market in EMEA, Asia, & South America (2007&2010): Percentage Market Share Breakdown of Leading Players – Medtronic, Boston Scientific (Guidant), St Jude Medical, and Others (includes corresponding Graph/Chart).....II-25
1$300
   Table 18: Core Pacemakers & CRT-P Market in EMEA, Asia, & South America (2007&2010): Percentage Market Share Breakdown of Leading Players – Medtronic, St. Jude, Boston Scientific and Others (includes corresponding Graph/Chart).....II-26
Focus on Select Markets.....II-26
Europe.....II-26
1$100
   Highly Competitive External Defibrillators Market Paves Way for
  Consolidations.....II-27
UK .....II-27
1$100
   Asia-Pacific .....II-28
China.....II-28
1$100
   B. Market Analytics.....II-29
Table 19: Rest of World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-29
1$300
   Table 20: Rest of World Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2005 (includes corresponding Graph/Chart).....II-30

Table 21: Rest of World 10-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-30
1$300
  3. PRODUCT OVERVIEW.....II-3112 $1200  
   Sudden Cardiac Arrest: A Leading Cause of Death.....II-31
Cardiac Rhythm Management (CRM): A Definition .....II-31
Implantable Cardioverter Defibrillators (ICDs).....II-31
1$100
   Surgical Implantation of ICDs: The Procedure .....II-32
ICDs – The Benefits .....II-32
1$100
   Types of ICDs.....II-33
ICDs: An Evolution Scan.....II-33
Complications Associated With ICD Usage.....II-33
CRT-D – A New Therapeutic Device.....II-33
1$100
   Pacemakers.....II-34
Surgical Implantation of Pacemakers: The Procedure .....II-34
Types of Pacemakers .....II-34
1$100
   Methods of Pacing.....II-35
Fixed Rate Pacemakers.....II-35
Demand Pacemakers.....II-35
Rate-Responsive Pacemaker.....II-35
1$100
   Pacemakers: An Evolution Scan.....II-36
Complications Associated with Pacemakers.....II-36
Advent of CRT-P.....II-36
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA).....II-36
1$100
   The Ablation Procedure.....II-37
External Defibrillators.....II-37
1$100
   Types of AEDs.....II-38
Cardiac Rhythm Disorders: A Brief Review .....II-38
1$100
   Cardiac Arrhythmias.....II-39
Classification of Cardiac Arrhythmias .....II-39
Bradycardia.....II-39
1$100
   Tachycardia.....II-40
Atrial Fibrillation.....II-40
1$100
   Heart Blocks .....II-41
Syncope.....II-41
Sick Sinus Syndrome.....II-41
1$100
   Cardiomyopathy.....II-42
1$100
  4. PRODUCT APPROVALS/INTRODUCTIONS.....II-4331 $3100  
   Biosense Catheter Receives FDA Marketing Approval.....II-43
St. Jude Medical Secures Approval for Atlas II ICD from Japan.....II-43
Zoll Medical Defibrillators Receive FDA Clearance.....II-43
St. Jude Medical Receives CE Mark for Integrated Irrigation Pump and Ablation
  Generator.....II-43
1$100
   AtriCure Secures FDA 510(k) Approval for Coolrail Device.....II-44
Hansen Medical Gains FDA Approval for CoHesion™ Module.....II-44
1$100
   St. Jude Medical Obtains CE Mark and FDA Approval for HIFU Surgical Ablation
  Solutions.....II-45
Biosense Releases NAVISTAR® RMT THERMOCOOL® Catheter.....II-45
Atricure Unveils The ORLab™.....II-45
1$100
   Cardima Receives SFDA Approval to Market INTELLITEMP® in China.....II-46
ZOLL Obtains 510K Clearance to Sell and Market Zoll R Series Code-Ready
  Defibrillator.....II-46
1$100
   ST. Jude Medical Obtains FDA and CE Mark Approval for New Epicor LP Cardiac Ablation
  System.....II-47
Cardima Obtains Approval for Marketing Surgical Ablation System in Thailand.....II-47
ATS Medical Introduces First CryoMaze Surgical Ablation Clamp.....II-47
CardioNet Unveils New Reporting Package for Atrial Fibrillation Treatment.....II-47
1$100
   Boston Scientific Defibrillator Receives CE Mark Approval.....II-48
TyRx Introduces New Anti-bacterial Envelope, AIGISRX™ ICD.....II-48
1$100
   St. Jude Medical Receives Approval from Japanese MHLW.....II-49
Boston Scientific Secures FDA Approval for CRM Solutions.....II-49
Sorin Group Develops New-Generation CRT-D Implants.....II-49
BSC Secures CE Mark Approval for ALTRUA Pacemakers.....II-49
1$100
   Medtronic Secures FDA Approval for New Vision 3D Devices.....II-501$100
   Medtronic Obtains FDA Approval for Software Update.....II-51
St. Jude Medical Obtains FDA Approval for SJM Cardiac Monitor.....II-51
Boston Scientific Obtains Approval For Cognis CRT-D And Teligen ICD.....II-51
FDA Approves Medtronic’s Medtronic Sprint Quattro Secure® S Lead.....II-51
1$100
   Medtronic Obtains CE Mark Approval for Pacemaker and Pacing Leads.....II-52
St. Jude Medical Obtains Japanese Approval for Victory® Pacemakers Family .....II-52
Sorin Group Obtains Approval For Isoline Defibrillation Leads In Japan.....II-52
1$100
   BSC Secures FDA Approval for New ALTRUA Pacemakers.....II-53
St. Jude Medical Obtains Approval for Durata Defibrillation Lead.....II-53
1$100
   St. Jude Medical Obtains Japanese Approval for Durata Defibrillation Lead .....II-54
St. Jude Medical Obtains Japanese Approval for Victory Family of Pacemakers .....II-54
Sorin Group Gains FDA Approval for OVATIO™.....II-54
Sorin SpA Gains FDA Approval for REPLY.....II-54
1$100
   Medtronic Receives Approval for Lead Integrity Alert™.....II-55
Physio-Control Gains FDA Approval for LIFEPAK® 20e Defibrillator/Monitor .....II-55
TyRx Introduces New Anti-Bacterial Envelope, AIGISRX™ ICD.....II-55
1$100
   LifeWatch Introduces Next-Generation Monitor, LifeStar ACT III Platinum.....II-56
eCardio Launches eVolution, New Cardiac Monitoring System.....II-56
Philips Introduces PageWriter TC70 Cardiograph.....II-56
1$100
   Sorin Group Announces Commercial Release and First Implant of PARADYM™ CRT
  8750.....II-57
St. Jude Medical Introduces QuickOpt® Timing Cycle Optimization in CRT-D .....II-57
Cardiac Science Unveils Simple Electronic Reporting System.....II-57
1$100
   Mennen Medical Introduces VitaLogik® 4000 Line.....II-58
BIOTRONIK Releases CRT-P in US Market.....II-58
1$100
   Vermed Releases Defibrillation Pads Series and Universal Connector System .....II-59
St. Jude Releases Reflexion Spiral X™ in US.....II-59
1$100
   St. Jude Introduces Therapy Cool Path.....II-60
Ablation Frontiers Obtains CE Marks and Commercially Launches Cardiac Ablation
  System.....II-60
Isolator® Bipolar Ablation Clamp System of AtriCure Obtains FDA 510(k)
  Clearance.....II-60
1$100
   Hansen Medical Receives CE Mark Approval for Sensei Robotic Catheter System and
  Artisan Control Catheter.....II-61
ZOLL AED Pro Secures FDA Approval for Use with See-Thru CPR™ Technology.....II-61
European Approval for CardioFocus’s Endoscopic Ablation System.....II-61
1$100
   Leipzig’s Heart Centre Unveils New Catheter Ablation Solution.....II-62
CardioFocus Receives CE Mark for Endoscopic Ablation System.....II-62
1$100
   FDA Approves SOLAR™ Surgical Ablation System of MedicalCV.....II-63
Cardima Launches Cardima Surgical Ablation Probe with 24 Electrodes.....II-63
Stereotaxis Receives Approval from FDA for a 8mm Ablation Catheter.....II-63
Japan Approves Sprint Quattro™ of Medtronic.....II-63
1$100
   Boston Scientific Receives European Clearance for CONFIENT™ ICD.....II-64
St. Jude Receives Japanese Approval for CRT-D Systems.....II-64
1$100
   St. Jude Receives CE Mark and FDA Approval for QuickOpt™ .....II-65
Hansen Medical Unveils Sensei™ Robotic Catheter System.....II-65
St. Jude Medical Receives FDA Approval for Two Devices.....II-65
1$100
   St. Jude Medical Obtains European CE Mark Clearance for Cardiac Devices .....II-66
St. Jude Medical Receives Approval for Pacemaker in the US and UK.....II-66
1$100
   Boston Scientific Receives FDA Approval for ACUITY® Steerable Lead .....II-67
St. Jude Medical Receives FDA Approval for its New CRM Device.....II-67
The Sorin Group Receives CE Mark for Its New Reply™ Pacemakers.....II-67
1$100
   St. Jude Medical Receives FDA Approval for Merlin.net Patient Care Network.....II-68
Europe Approves Implantable Cardiac Rhythm Appliance of Boston Scientific .....II-68
CE Mark and FDA Approve Zephyr™ Pacemaker of St. Jude.....II-68
1$100
   FDA Gives Clearance for Atlas II+ HF CRT-D of St. Jude.....II-69
St Jude Medical Receives Approval from Japan .....II-69
Sorin Launches REPLY Following CE Mark Certification.....II-69
1$100
   BIOTRONIK Launches Lumax 340 VR-T XL ICD.....II-70
Medtronic to Launch Medtronic CareLink Network in EU.....II-70
St. Jude Medical Receives Approval for Using CRT-D Systems in Japan.....II-70
1$100
   St. Jude Medical Receives FDA Approval for Promote CRT-D and Current ICD .....II-71
Bio-Detek Receives FDA Approval for PocketCPR™.....II-71
EZ STEER Bi-Directional Catheter for Treating Abnormal Cardiac Rhythms.....II-71
1$100
   Philips Unveils EP Navigator Tool for Complex Cardiac Arrhythmias.....II-72
Medtronic Launches Advanced Cardiac Defibrillators with Wireless Feature .....II-72
1$100
   Sorin Group Introduces OVATIO Implantable Cardioverter Defibrillators.....II-73
1$100
  5. RECENT INDUSTRY ACTIVITY.....II-7421 $2100  
   Medtronic Takes Over Ablation Frontiers.....II-74
Philips Signs a Deal with Bard Electrophysiology.....II-74
Boston Scientific Bags CRM Contract from Dept. of Veterans Affairs.....II-74
1$100
   Medtronic and Boston Scientific Inks Agreement to End IP Disputes.....II-75
St Jude Medical to Invest in Penang.....II-75
Cardima Enters into a Distribution Agreement with Peerless Medical.....II-75
1$100
   Cardiac Science Enters into an Alliance with Boy Scouts of America.....II-76
Cardima Enters into a New Strategic Surgical Alliance with Biocore.....II-76
Cardima Enters into a New Strategic Marketing Alliance with On-X Life
  Technologies.....II-76
1$100
   Welch Allyn and ZOLL Medical Corporation Collaborate.....II-77
Cardima Selects Dot Medical to Distribute Its EP Products in the UK.....II-77
1$100
   Royal Philips to Guide ‘euHeart’ Project.....II-78
Target Center Acquires HeartSine® Defibrillators.....II-78
St Jude Medical Acquires EP MedSystems .....II-78
St. Jude Takes Over Radi Medical AB .....II-78
1$100
   Medrad to Acquire Possis.....II-79
Phoenix Acquires Stake in Possis.....II-79
Biotronik Acquires VascoMed.....II-79
1$100
   Medtronic Takes Over CryoCath Technologies .....II-80
Boston Scientific Takes Over CryoCor.....II-80
St. Jude Completes Acquisition of MediGuide.....II-80
Greatbatch Enters Into A Strategic Partnership With Issys.....II-80
1$100
   Sorin Group Inks Collaborative Agreement with Greatbatch.....II-81
Philips Enters into MOU with King’s College London on Research Collaboration .....II-81
Welch Allyn Collaborates with ZOLL Medical Corporation.....II-81
1$100
   ZOLL and HealthTrust Sign Purchasing Deal.....II-82
ZOLL Inks Multi-Year Agreement with Masimo.....II-82
First Responder Wins Contract from Harvard School of Public Health.....II-82
1$100
   Beijing Airport Group to Deploy ZOLL AED Plus Solutions.....II-83
STH NHS Trust to Deploy New R Series BLS Solutions of ZOLL.....II-83
Major EMS Centers in China Deploys ZOLL M Series Defibrillator.....II-83
1$100
   DRF to Deploy corpuls3 Heart Defibrillators.....II-84
Riedel & Schulz and GS Elektromed Distributes 8 corpuls3 Medical Units .....II-84
Trivitron Inks Marketing And Distribution Agreement With Boston Scientific .....II-84
CardioComm Signs Licensing Agreement with GE Healthcare.....II-84
1$100
   Cambridge Heart Licenses Technology for Implantable Devices.....II-85
Synovis Life Technologies to Divest Interventional Business.....II-85
Boston Scientific Divests Cardiac Surgery And Vascular Surgery Businesses.....II-85
Sorin Group Sells Its Vascular Therapy Business to CIDl.....II-85
1$100
   Medtronic and Biosense Webster Enter Into Alliance for Advance Cardiac
  Ablation.....II-86
ATS Medical Takes Over Surgical Ablation Business of CryoCath.....II-86
Biosense Webster Enters into a Strategic Alliance with Medtronic.....II-86
1$100
   Atricure Takes Over Frigitronics® Cryogenic Product Series.....II-87
Boston Scientific Announces Approval and Launch of VITALITY™ DR ICD.....II-87
Boston Scientific to Reallocate Resources for R&D in CRM .....II-87
1$100
   Vicor Technologies Merges with SRKP 6.....II-88
Greatbatch Takes Over Biomec.....II-88
Greatbatch Completes Quan Emerteq Acquisition.....II-88
1$100
   Greatbatch Takes Over Enpath Medical .....II-89
Medtronic to Take Over MRI Safety Patents of Biophan.....II-89
Teleflex Takes Over Arrow.....II-89
Edwards Acquires CardioVations Division.....II-89
1$100
   Boston Scientific Inks Deal to Take Over Remon Medical Technologies.....II-90
Sorin and Japan Lifeline Sign Ten-Year CRM Partnership.....II-90
Royal Philips Joins Hands with Healthcare Entities .....II-90
Triple Ring Forms Partnership with Aubrey.....II-90
1$100
   SurModics and St. Jude Medical Sign Corporate Technology Agreement .....II-91
Siemens Medical Solutions Extends Strategic Alliance with Biosense Webster.....II-91
Hansen and St. Jude Enter into Agreements.....II-91
1$100
   St. Jude Medical Secures a Cardiac Rhythm Management Devices Contract.....II-92
Biotronik Secures Cardiac Rhythm Management Contract from Premier.....II-92
ZOLL Selected to Supply Emergency Preparedness Equipment.....II-92
1$100
   Edwards Lifesciences Announces Multi-Year Grant to University of California .....II-93
St. Jude Medical Announced Plans to Expand Operations in Puerto Rico.....II-93
1$100
   Biophan to Make Investment in Myotech.....II-94
1$100
  6. FOCUS ON SELECT PLAYERS.....II-953 $300  
   Bard Electrophysiology (USA).....II-95
Biosense Webster, Inc. (USA).....II-95
Boston Scientific Corporation (USA).....II-95
Biotronik GMBH & Co. KG (Germany).....II-95
1$100
   Medtronic, Inc. (USA).....II-96
Medtronic CryoCath LP (USA).....II-96
Vitatron Nederland BV (Netherlands) .....II-96
1$100
   Philips Healthcare (The Netherlands).....II-97
St. Jude Medical, Inc. (USA).....II-97
Sorin Group (Italy).....II-97
1$100
  7. GLOBAL MARKET PERSPECTIVE.....II-984 $1200  
   Table 22: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Geographic Region – United States and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-981$300
   Table 23: World Historic Review for Cardiac Rhythm Management Devices by Geographic Region – United States and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2005 (includes corresponding Graph/Chart).....II-99

Table 24: World 10-Year Perspective for Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Dollar Sales for United States and Rest of World for Years 2006, 2009 & 2015.....II-99
1$300
   Table 25: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-100

Table 26: World Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardiac Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2005 (includes corresponding Graph/Chart).....II-100
1$300
   Table 27: World 10-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-1011$300
III. COMPETITIVE LANDSCAPE 353$995
  
Total Companies Profiled: 59 (including Divisions/Subsidiaries - 146)

Region/Country                 Players


The United States                40
Canada                            7
Japan                             8
Europe                           75
     France                       8
     Germany                     17
     The United Kingdom           8
     Italy                        8
     Spain                        7
     Rest of Europe              27
Asia-Pacific (Excluding Japan)   12
Latin America                     3
South Africa                      1
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.